Results 201 to 210 of about 120,498 (339)

Revolutionizing Veterinary Medicine: The Role of Nanoparticles in Advancing Animal Health, Nutrition and Disease Management

open access: yesVeterinary Medicine and Science, Volume 11, Issue 5, September 2025.
Nanoparticles are transforming animal care by enhancing nutrition, drug delivery and disease prevention. This study highlights their role in improving nutrient absorption in livestock, facilitating targeted drug delivery and boosting vaccine efficacy. Additionally, nanoparticles effectively reduce harmful mycotoxins in animal feeds, promoting overall ...
Mohsen Kazemi
wiley   +1 more source

Triosephosphate isomerase from Fasciola hepatica: high‐resolution crystal structure as a drug target

open access: yesActa Crystallographica Section F, Volume 81, Issue 9, Page 381-387, September 2025.
The high‐resolution crystal structure of triosephosphate isomerase from F. hepatica was solved at 1.51 Å resolution in its monoclinic form, revealing details of the dimer interface critical for enzyme function. Molecular docking with the fasciolocide triclabendazole suggests selective binding near nonconserved residues, highlighting this enzyme as a ...
Georgios Kontellas   +5 more
wiley   +1 more source

Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single‐Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as ‘Non‐Pathogenic’

open access: yesAPMIS, Volume 133, Issue 9, September 2025.
ABSTRACT Clinical microbiology involves the detection and differentiation of primarily bacteria, viruses, parasites and fungi in patients with infections. Billions of people may be colonised by one or more species of common luminal intestinal parasitic protists (CLIPPs) that are often detected in clinical microbiology laboratories; still, our knowledge
Christen Rune Stensvold
wiley   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 9, Page 1537-1566, September 2025.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Parasitology [PDF]

open access: yes, 2005
Cox, F   +3 more
core   +2 more sources

Pharmacological Inhibition of c‐Jun N‐Terminal Kinase Activity Exacerbates Liver Damage in Schistosoma mansoni Infected Mice

open access: yesLiver International, Volume 45, Issue 9, September 2025.
ABSTRACT Background and Aims Schistosomiasis is a neglected tropical disease affecting more than 250 million people worldwide. Eggs of the parasitic helminth S. mansoni cause major morbidity in the liver, spleen and intestine. Of note, egg‐released soluble antigens (SEA) induce the transcription factor c‐Jun in hepatocytes, promoting hepatocellular ...
Frederik Stettler   +18 more
wiley   +1 more source

Postglacial Echoes: Parasite Genomics Uncover Environmental Changes in Postglacial European Lakes

open access: yesMolecular Ecology, Volume 34, Issue 17, September 2025.
ABSTRACT Postglacial environmental changes have influenced biodiversity and species evolution, yet the genomic and demographic responses of parasites remain underexplored. This study investigates the population genetics and demographic history of the flatworm Phyllodistomum umblae, a generalist trematode at the definitive host level infecting Coregonus
Mar Llaberia‐Robledillo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy